Equillium, Inc. (EQ)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.67−$0.0500 (−2.91%) on the dayAs of the close; data may be delayed.
EQ price, last 12 months
Key stats
- Previous close
- $1.72
- Open
- $1.70
- Day range
- $1.66 – $1.71
- 52-week range
- $0.7562 – $3.54
- Volume
- 137.8K
- Avg volume (20 days)
- 544.4K
- Market cap
- $105.9M
Performance
1W−13.0%
1M−29.2%
3M−45.3%
6M−18.9%
YTD+7.7%
1Y+16.0%
vs S&P 500, 1Y−0.8 pts
Technicals and fundamentals
About Equillium, Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $105.9M